Wyeth Kicks Off “Project Impact” As Protonix Generics Threaten Bottom Line
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug revenues jump 10 percent for the fourth quarter and full year, and dual-fronted patent fight goes on.
You may also be interested in...
Merck Cuts U.S. Sales Force By 1,200
Combined with earlier cutbacks, Merck has eliminated 1,600 positions, or 20 percent, of its force since 2005, firm tells the DAILY.
Merck Cuts U.S. Sales Force By 1,200
Combined with earlier cutbacks, Merck has eliminated 1,600 positions, or 20 percent, of its force since 2005, firm tells the DAILY.
Wyeth Pulls Plug On Trubion Candidate In NHL
Firms forge ahead with rheumatoid arthritis program.